Drug repurposing: progress, challenges and recommendations

S Pushpakom, F Iorio, PA Eyers, KJ Escott… - Nature reviews Drug …, 2019 - nature.com
Given the high attrition rates, substantial costs and slow pace of new drug discovery and
development, repurposing of'old'drugs to treat both common and rare diseases is …

RhoA signaling in neurodegenerative diseases

SI Schmidt, M Blaabjerg, K Freude, M Meyer - Cells, 2022 - mdpi.com
Ras homolog gene family member A (RhoA) is a small GTPase of the Rho family involved in
regulating multiple signal transduction pathways that influence a diverse range of cellular …

Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis

M Jin, R Günther, K Akgün, A Hermann, T Ziemssen - Scientific reports, 2020 - nature.com
Neuroinflammation is involved in the pathogenesis of amyotrophic lateral sclerosis (ALS),
but only limited data are available on systematic peripheral and central immune cell profiles …

Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases

Q Wang, LJ Song, ZB Ding, Z Chai, JZ Yu… - Neural regeneration …, 2022 - journals.lww.com
Ras homolog (Rho)-associated kinases (ROCKs) belong to the serine-threonine kinase
family, which plays a pivotal role in regulating the damage, survival, axon guidance, and …

[HTML][HTML] Fluoride exposure disrupts the cytoskeletal arrangement and ATP synthesis of HT-22 cell by activating the RhoA/ROCK signaling pathway

L Chen, P Jia, Y Liu, R Wang, Z Yin, D Hu… - Ecotoxicology and …, 2023 - Elsevier
Background Fluoride, an environmental contaminant, is ubiquitously present in air, water,
and soil. It usually enters the body through drinking water and may cause structural and …

Protein kinase inhibitors for amyotrophic lateral sclerosis therapy

V Palomo, V Nozal, E Rojas‐Prats… - British Journal of …, 2021 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder that causes the
progressive loss of motoneurons and, unfortunately, there is no effective treatment for this …

Modulation of microglial activity by Rho-kinase (ROCK) inhibition as therapeutic strategy in Parkinson's disease and amyotrophic lateral sclerosis

AE Roser, L Tönges, P Lingor - Frontiers in aging neuroscience, 2017 - frontiersin.org
Neurodegenerative diseases are characterized by the progressive degeneration of neurons
in the central and peripheral nervous system (CNS, PNS), resulting in a reduced innervation …

Pharmacologic inhibition of LIMK1 provides dendritic spine resilience against β-amyloid

BW Henderson, KM Greathouse, R Ramdas… - Science …, 2019 - science.org
Alzheimer's disease (AD) therapies predominantly focus on β-amyloid (Aβ), but Aβ effects
may be maximal before clinical symptoms appear. Downstream of Aβ, dendritic spine loss …

Rho kinase inhibitor fasudil reduces l‐DOPA‐induced dyskinesia in a rat model of Parkinson's disease

A Lopez‐Lopez, CM Labandeira… - British Journal of …, 2020 - Wiley Online Library
Background and Purpose Rho kinase (ROCK) activation is involved in neuroinflammatory
processes leading to progression of neurodegenerative diseases such as Parkinson's …

Perspectives on ROCK2 as a Therapeutic Target for Alzheimer's Disease

AJ Weber, JH Herskowitz - Frontiers in Cellular Neuroscience, 2021 - frontiersin.org
Rho-associated coiled-coil containing kinase isoform 2 (ROCK2) is a member of the AGC
family of serine/threonine kinases and an extensively studied regulator of actin-mediated …